Valuation: GENFIT

Market Cap 662M 765M 619M 566M 1.07B 72.97B 1.08B 7.26B 2.85B 36.5B 2.87B 2.81B 122B P/E 2026 *
34.2x
P/E 2027 * 87.9x
Enterprise Value 611M 706M 571M 522M 984M 67.34B 999M 6.7B 2.63B 33.69B 2.65B 2.59B 112B EV / Sales 2026 *
6.1x
EV / Sales 2027 * 4.81x
Free-Float
86.89%
Yield 2026 *
-
Yield 2027 * -
1 day-1.66%
1 week-8.95%
Current month-11.19%
1 month-3.56%
3 months+46.95%
6 months+93.75%
Current year+147.29%
1 week 12.88
Extreme 12.88
14.66
1 month 12.34
Extreme 12.34
15.48
Current year 5.05
Extreme 5.05
15.48
1 year 3.05
Extreme 3.048
15.48
3 years 2.62
Extreme 2.62
15.48
5 years 2.62
Extreme 2.62
15.48
10 years 2.62
Extreme 2.62
35.65
Manager TitleAgeSince
Chief Executive Officer 58 16/09/2019
Director of Finance/CFO 52 22/04/2021
Chief Tech/Sci/R&D Officer - 27/11/2025
Director TitleAgeSince
Chairman 70 16/06/2017
Director/Board Member 54 15/09/1999
Director/Board Member 58 16/06/2017
Date Insider Type Main position Quantity % Market Cap.
12/7/23 Buy

Director

5,300 0.0106%
7/7/23 Buy

Chief Executive Officer

10,000 0.0201%
7/7/23 Buy

Founder

10,000 0.0201%
Change 5-day change 1-year change 3-year change Capi.($)
-1.51%-8.95%+290.29%+277.39% 765M
-0.86%+3.34%+6.25%+16.19% 50.03B
+0.89%+13.44%+491.34%+594.30% 44.36B
+3.08%+14.42%+24.57%+81.39% 40.82B
+1.38%+3.70%+34.54%+9.11% 39.83B
+0.85%+10.32%+21.22%+47.64% 32.51B
+0.08%+5.00% - - 16.85B
+1.99%+5.08%+38.70%+125.08% 16.81B
-0.37%+1.45%+5.37%+21.22% 14.05B
+3.56%+19.98%+86.23%+27.29% 13.22B
Average +0.91%+253.11%+110.95%+133.29% 26.93B
Weighted average by Cap. +1.07%+294.23%+108.03%+140.18%

Financials

2026 *2027 *
Net sales 100M 116M 93.65M 85.59M 161M 11.04B 164M 1.1B 431M 5.52B 435M 425M 18.39B 124M 143M 116M 106M 200M 13.67B 203M 1.36B 534M 6.84B 538M 526M 22.77B
Net income 22.88M 26.43M 21.38M 19.54M 36.83M 2.52B 37.41M 251M 98.4M 1.26B 99.23M 97.07M 4.2B 6.8M 7.85M 6.36M 5.81M 10.95M 749M 11.12M 74.53M 29.25M 375M 29.49M 28.85M 1.25B
Net Debt -51.12M -59.05M -47.78M -43.67M -82.29M -5.63B -83.58M -560M -220M -2.82B -222M -217M -9.38B -66.17M -76.44M -61.85M -56.53M -107M -7.29B -108M -725M -285M -3.65B -287M -281M -12.15B
Logo GENFIT
GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA).
Employees
161
Date Price Change Volume
11/08/26 EUR 13.30 +0.45% 104,134
10/08/26 EUR 13.24 -3.07% 390,348
07/08/26 EUR 13.66 -0.44% 165,976
06/08/26 EUR 13.72 -2.56% 263,306
05/08/26 EUR 14.08 -1.54% 237,999
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
13.24EUR
Average target price
15.90EUR
Spread / Average Target
+20.09%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GNFT Stock